A clinical study is assessing whether a specific type of rehabilitation therapy — called neurologic music therapy — may help people with Parkinson’s disease recover fine motor skills, such as those required for writing, self-care, and fine object manipulation. The trial (NCT03049033) is underway at the University of…
Altoida announced a three-year collaboration with a Greek university to investigate whether the company’s precision neurology medical device can aid in the early detection of Parkinson’s disease. The agreement between Altoida and scientists at the Bioinformatics and Human Electrophysiology Laboratory (BiHELab), part of Ionian University in Corfu,…
Scientists have created wearable, flexible sensors — which can be integrated into fabrics, and detect touch pressure as well as measure body movements — that may be used to gauge motor disease progression in people with Parkinson’s, a study reported. Placing the sensors in the soles of patients’ shoes…
A new tool that analyzes speech using real-world, web-based recordings — participants are recorded via a webcam and a microphone connected to a personal computer or laptop — identified Parkinson’s disease patients with 74% accuracy, a study demonstrated. Moreover, this speech tool — called Parkinson’s Analysis with Remote Kinetic-tasks,…
More research is needed to understand how alpha-synuclein — a protein whose accumulation is characteristic of Parkinson’s disease — affects cells other than nerve cells, particularly microglia, the resident immune cell of the brain. A pair of researchers at the Van Andel Institute in Michigan raised this argument after…
Neuropathy, or nerve damage, was linked to abnormally low levels of the vitamins B6 and B12 in three people with Parkinson’s disease, according to a case report. “All patients were consecutively identified within one year at a single institution,” the researchers wrote, which suggests that neuropathy associated with low levels…
Reduced dopamine signaling leads to abnormal activity in the motor cortex— the part of the brain chiefly responsible for controlling movement — a new study in mice illustrates. This result helps to shed light on the biological underpinnings of Parkinson’s disease, which is characterized by abnormally low dopamine levels…
The first Parkinson’s patient has been dosed in a Phase 1 clinical trial that is testing IkT-148009, an investigational oral therapy being developed by Inhibikase Therapeutics to slow or stop disease progression. “We are pleased to begin dosing patients in our Phase 1b study,” Milton Werner, PhD,…
A grant from the Parkinson Voice Project will be used to enhance the training and resources available to speech language pathologists and graduate students with the RiteCare Center for Communication Disorders at Georgia Southern University. Such awards, whose sum was not disclosed, are given annually by Parkinson Voice Project (PVP) through…
Mapping of a brain circuit that is of particular relevance to neurological diseases such as Parkinson’s and Huntington’s revealed key features about its architecture and information flow, a study in mice reported. This brain circuit involves a looping connection between the cortex, the basal ganglia, and the thalamus…
Get regular updates to your inbox.